loadpatents
Patent applications and USPTO patent grants for Oden; Lourdes Salvador.The latest application filed is for "protease inhibitors".
Patent | Date |
---|---|
Protease inhibitors Grant 11,312,693 - Oden , et al. April 26, 2 | 2022-04-26 |
Protease Inhibitors App 20210017140 - ODEN; Lourdes Salvador ;   et al. | 2021-01-21 |
Protease inhibitors Grant 10,723,709 - Oden , et al. | 2020-07-28 |
Protease Inhibitors App 20200010434 - ODEN; Lourdes Salvador ;   et al. | 2020-01-09 |
Protease inhibitors Grant 10,329,266 - Oden , et al. | 2019-06-25 |
Respiratory Syncytial Virus Inhibitors App 20190002436 - AYESA; Susana ;   et al. | 2019-01-03 |
Protease Inhibitors App 20180327371 - ODEN; Lourdes Salvador ;   et al. | 2018-11-15 |
Protease Inhibitors App 20170334867 - ODEN; Lourdes Salvador ;   et al. | 2017-11-23 |
Protease Inhibitors App 20170166538 - ODEN; Lourdes Salvador ;   et al. | 2017-06-15 |
Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-b- utyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitor Grant 9,650,388 - Grabowska , et al. May 16, 2 | 2017-05-16 |
Protease inhibitors Grant 9,428,517 - Oden , et al. August 30, 2 | 2016-08-30 |
Form 2 Crystalline Polymorph Of A Salt Of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-b- Utyl]-4-[5-fluoro-2-(4-methyl-piperazinyl)thiazol-4-yl]-benzamide Useful As Cysteine Protease Inhibitor App 20160194334 - GRABOWSKA; Urszula ;   et al. | 2016-07-07 |
Protease Inhibitors App 20160068539 - ODEN; Lourdes Salvador ;   et al. | 2016-03-10 |
Protease inhibitors Grant 9,200,006 - Oden , et al. December 1, 2 | 2015-12-01 |
Protease Inhibitors App 20140221654 - ODEN; Lourdes Salvador ;   et al. | 2014-08-07 |
Protease inhibitors Grant 8,735,395 - Oden , et al. May 27, 2 | 2014-05-27 |
Protease Inhibitors App 20130231349 - ODEN; Lourdes Salvador ;   et al. | 2013-09-05 |
Cysteine protease inhibitors Grant 8,466,158 - Nilsson , et al. June 18, 2 | 2013-06-18 |
Protease inhibitors Grant 8,426,421 - Oden , et al. April 23, 2 | 2013-04-23 |
Protease Inhibitors App 20120289519 - ODEN; Lourdes Salvador ;   et al. | 2012-11-15 |
Protease inhibitors Grant 8,242,119 - Oden , et al. August 14, 2 | 2012-08-14 |
Cysteine protease inhibitors Grant 8,198,283 - Nilsson , et al. June 12, 2 | 2012-06-12 |
Non-nucleoside reverse transcriptase inhibitors Grant 7,405,310 - Lindstrom , et al. July 29, 2 | 2008-07-29 |
Non-nucleoside reverse transcriptase inhibitors App 20050240035 - Lindstrom, Stefan ;   et al. | 2005-10-27 |
Intermediate compounds of non-nucleoside reverse transcriptase inhibitors Grant 6,894,177 - Lindstrom , et al. May 17, 2 | 2005-05-17 |
Non-nucleoside reverse transcriptase inhibitors Grant 6,716,850 - Lindstrom , et al. April 6, 2 | 2004-04-06 |
Non-nucleoside reverse transcriptase inhibitors App 20030187266 - Lindstrom, Stefan ;   et al. | 2003-10-02 |
Non-nucleoside reverse transcriptase inhibitors App 20030069224 - Lindstrom, Stefan ;   et al. | 2003-04-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.